8Scott D L, Kingsley G H. Tumor necrosis factor inhibitors for rheumatoid arthritis[J]. NEngJMed, 2006,355 (7): 704-712.
9Shanahan J C, Moreland L W, Carter R H. Upcoming biologic agents for the treatment of rheumatic diseases[J]. Curr Opin Rheumatol, 2003, 15(3):226-236.
10Saag K G, Teng G G, Patkar N M, et al. American college of rheumatology 2008 recommendations for the use of nonbiologic and biologic disease- modifying antirheumatic drugs in rheumatoid arthritis[J]. Arthritis Rheum, 2008, 59(6):762-784.
4Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：82
